Development of a Multiplex Autoantibody Test for Detection of Lung Cancer
Lung cancer is the leading cause of cancer-related deaths for both men and women. Early diagnosis of lung cancer has a 5-year survival rate of 48.8%, however, nearly 35% of stage I patients relapses after surgical resection, thus portending a poor prognosis. Therefore, detecting lung cancer in early...
Main Authors: | Jia, Jing, Wang, Wenzhe, Meng, Wen, Ding, Mingjian, Ma, Shenglin, Wang, Xiaoju |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995760/ |
Similar Items
-
Multiplexed Serum Biomarkers for the Detection of Lung Cancer
by: Ma, Shenglin, et al.
Published: (2016) -
MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
by: Li, Weili, et al.
Published: (2016) -
A novel autoantibody test for the detection of pre-neoplastic lung lesions
by: Lowe, Frazer J, et al.
Published: (2014) -
Comparison of multiplex, ELISA and immunofluorescence for detecting autoantibodies in JIA patients
by: Fawcett, Paul T, et al.
Published: (2012) -
The Uses and Misuses of Multiplex Autoantibody Assays in Systemic Autoimmune Rheumatic Diseases
by: Satoh, Minoru, et al.
Published: (2015)